Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

DHT, a testosterone byproduct, causes male pattern baldness.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Testosterone helps human pancreatic cells increase insulin release.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

OXTR agonists may promote hair growth and be effective for treating hair loss.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Androgens can both increase and decrease hair growth in different parts of the body.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The HR protein's role as a repressor is essential for controlling hair growth.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.